TARS Competitors & Alternatives
Compare Tarsus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
TARS
Main Stock$73.00
Tradestie Score
51
Market Cap
$2.42B
Revenue Growth
0.7%
Analyst Upside
+36.3%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$24.33
|
$3.83B | - | 58 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.37
|
$3.68B | - | 60 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$82.93
|
$3.67B | - | 46 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.72
|
$3.59B | 14.2 | 34 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.95
|
$3.58B | 9.0 | 62 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$302.96
|
$3.49B | 32.1 | 44 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.55
|
$3.40B | 107.2 | 39 | Compare |
|
QURE
uniQure N.V.
|
$23.46
|
$3.39B | - | 48 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$46.81
|
$3.33B | - | 68 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$23.20
|
$3.31B | - | 53 | Compare |
More TARS Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
226 stocks in this industry